X. Ligneau et al., Distinct pharmacology of rat and human histamine H-3 receptors: role of two amino acids in the third transmembrane domain, BR J PHARM, 131(7), 2000, pp. 1247-1250
Starting from the sequence of the human histamine H-3 receptor (hH(3)R) cDN
A, we have cloned the corresponding rat cDNA. Whereas the two deduced prote
ins show 93.5% overall homology and differ only by five amino acid residues
at the level of the transmembrane domains (TMs), some ligands displayed di
stinct affinities. Thioperamide and ciproxifan were about 10 fold more pote
nt at the rat than at the human receptor, whereas FUB 349 displayed a rever
se preference. Histamine, (R)alpha -methylhistamine, proxyfan or clobenprop
it were nearly equipotent at H-3 receptors of both species. The inverse dis
crimination patterns of ciproxifan and FUB 349 were partially changed by mu
tation of one amino acid (V122A), and fully abolished by mutation of two am
ino acids (A119T and V122A), in TM3 of the rH(3)R located in the vicinity o
f Asp(114) purported to salt-link the ammonium group of histamine. Therefor
e, these two residues appear to be responsible for the distinct pharmacolog
y of the H3R in the two species.